- ScreenPro Security (SCRN) reports a significant increase in the Covid-19 testing numbers this year, contributing to the company’s stronger cash position
- Covid testing remains in high demand for the film and production and travel industries
- In March 2022, ScreenPro administered a total of 25,333 Covid-19 tests
- ScreenPro Security is a medical technology company that offers proprietary testing methods and medical alerting software
- ScreenPro Security Inc. (SCRN) opened trading at C$0.105 per share
ScreenPro Security (SCRN) reports a significant increase in the Covid-19 testing numbers this year, contributing to the company’s stronger cash position.
Covid testing remains in high demand for the film and production industry. Due to the nature of the work environment, staff members are often operating in contained areas and in close proximity. With various highly contagious variants, such as Omicron and the numbers of infections increasing, we foresee more contracts throughout 2022.
ScreenPro has also experienced a rise in demand for testing in the travel and tourism industry along with its concierge (home/office visit) services. The company has recently received three additional testing contracts in television and production, resulting in a total of 21 new productions to date for Q1 of FY22.
Recent testing numbers are as follows:
- December 2021 resulted in a total of 14,202 Covid-19 tests
- January 2022 resulted in a total of 19,446 Covid-19 tests
- February 2022 resulted in a total of 23,655 Covid-19 tests
- March 2022 resulted in a total of 25,333 Covid-19 tests
“As Canada faces a spike in Covid-19 cases and a possible sixth wave, the company continues to build momentum with the Covid testing business for the film and production industry. We have also increased our testing services in the travel industry to meet potential demand as more and more people are travelling internationally,” said Michael Yeung, Chairman of the company.
“The film industry is still feeling the strain of the pandemic and have to continuously turn to Covid testing to keep individuals safe whilst on set. As the need for Covid testing expands, and as more people travel, we are confident that our testing continues to yield great revenue and profitability. We also anticipate securing more contracts which will attribute to higher revenue and profit for our shareholders,” said Lena Kozovski, CEO of the company.
ScreenPro is a screening and medical technology company that provides turnkey screening solutions with its proprietary medical alerting software.
ScreenPro’s access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to provide COVID testing solutions across Canada.
ScreenPro has its own medical doctor and nursing professionals with on-the-ground support staff and transportation, with access to high-quality PPEs to ensure that clients are protected in all aspects of their testing needs.
ScreenPro Security Inc. (SCRN) opened trading at C$0.105 per share.